Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD28 specificity or anti-CD40 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can increase T-cell proliferation, induce DC maturation and prime efficacy of cytotoxic T cells. It is designed for the research of Acute myeloid leukaemic (AML) therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-CD40 Bispecific Antibody (scFv-Fc) (BSCFV-H232). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS